journal article·2020-12

ROS‐Responsive Camptothecin Prodrug Nanoparticles for On‐Demand Drug Release and Combination of Chemotherapy and Photodynamic Therapy

Bingyang Chu, Ying Qu, Xinlong He, Ying Hao, Chengli Yang, Yun Yang, Danrong Hu, Fangfang Wang, Zhiyong Qian

Advanced Functional Materials· Volume 30· Issue 52
Publisher page

Abstract

Abstract Minimizing drug leakage in systemic circulation, synchronizing the in vivo fate of multiple drugs, and precisely controlling tumor locoregional drug release, remain challenging for nanomedicine‐based cancer therapy. Here, a reactive oxygen species (ROS)‐responsive camptothecin (CPT) prodrug delivery system (MPEG‐(TK‐CPT)‐PPa) is developed, in which CPT and photosensitizer pyropheophorbide‐a (PPa) are concurrently conjugated to the same poly(ethylene glycol) methyl ether (MPEG) via ROS‐responsive thioketal (TK) and lipid linkage. The synthesized MPEG‐(TK‐CPT)‐PPa conjugate self‐assembles to form nanoparticles (NPs) (43.6 ± 0.8 nm) in solution. The covalently conjugated prodrug prevents drug leakage during systemic circulation and synchronizes the in vivo distribution of the two drugs. The generated fluorescence signal of PPa helps precisely track and locate the NPs at tumor sites. Under the guidance of imaging, a near‐infrared laser locally irradiates tumor tissue upon reaching the strongest fluorescence. The ROS generated by PPa not only cleaves the TK linkage and then triggers locoregional, controllable and on‐demand CPT release, but also exhibits cytotoxic effects on tumor cells. Thus, CPT‐mediated chemotherapy and PPa‐induced photodynamic therapy lead to the combined and enhanced suppression of tumor growth. Accordingly, such laser‐triggered, localized, controllable, and on‐demand drug release systems may provide an alternative option for CPT formulations.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Biotherapy and Cancer Center West China Hospital Sichuan University Collaborative Innovation Center for Biotherapy Chengdu Sichuan 610041 P. R. China

Department of Hematology and Research Laboratory of Hematology State Key Laboratory of Biotherapy West China Hospital Sichuan University Collaborative Innovation Center for Biotherapy Chengdu Sichuan 610041 P. R. China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation · West China Hospital, Sichuan University · Sichuan University

References (46)

Show source-provided references
1. 10.3322/caac.2156510.3322/caac.21565 ↗
2. 10.3322/caac.2155110.3322/caac.21551 ↗
3. 10.1016/S0140-6736(19)32591-710.1016/S0140-6736(19)32591-7 ↗
4. 10.1016/j.biomaterials.2020.11979110.1016/j.biomaterials.2020.119791 ↗
5. 10.1016/j.jconrel.2020.02.02510.1016/j.jconrel.2020.02.025 ↗
6. 10.1039/c2nr31517c10.1039/c2nr31517c ↗
7. 10.1016/j.ijpharm.2016.01.03010.1016/j.ijpharm.2016.01.030 ↗
8. 10.1016/j.ijpharm.2016.09.00510.1016/j.ijpharm.2016.09.005 ↗
9. 10.2165/00003495-200262140-0000410.2165/00003495-200262140-00004 ↗
10. 10.1016/j.jconrel.2016.12.02310.1016/j.jconrel.2016.12.023 ↗
11. 10.1016/j.bmcl.2016.12.08510.1016/j.bmcl.2016.12.085 ↗
12. 10.1038/nrc197710.1038/nrc1977 ↗
13. 10.1016/j.cclet.2018.10.00410.1016/j.cclet.2018.10.004 ↗
14. 10.1016/j.jconrel.2019.01.01610.1016/j.jconrel.2019.01.016 ↗
15. 10.1016/j.apmt.2018.11.00810.1016/j.apmt.2018.11.008 ↗
16. 10.1166/jbn.2017.247510.1166/jbn.2017.2475 ↗
17. 10.1002/adma.20160662810.1002/adma.201606628 ↗
18. 10.1002/adma.20170014110.1002/adma.201700141 ↗
19. 10.1021/ja909475m10.1021/ja909475m ↗
20. 10.1021/ja510584810.1021/ja5105848 ↗
21. 10.1021/ja409686x10.1021/ja409686x ↗
22. 10.1039/C7CS00557A10.1039/C7CS00557A ↗
23. 10.1016/j.addr.2016.06.01510.1016/j.addr.2016.06.015 ↗
24. 10.1016/j.addr.2017.06.01310.1016/j.addr.2017.06.013 ↗
25. 10.1038/am.2015.8310.1038/am.2015.83 ↗
26. 10.1016/j.biomaterials.2013.01.04110.1016/j.biomaterials.2013.01.041 ↗
27. 10.1016/j.cclet.2019.04.05210.1016/j.cclet.2019.04.052 ↗
28. 10.1016/j.biomaterials.2015.02.07810.1016/j.biomaterials.2015.02.078 ↗
29. 10.1016/j.cclet.2017.09.04810.1016/j.cclet.2017.09.048 ↗
30. 10.1002/anie.20170411710.1002/anie.201704117 ↗
31. 10.1016/j.cclet.2018.02.01010.1016/j.cclet.2018.02.010 ↗
32. 10.1016/j.biomaterials.2018.12.03210.1016/j.biomaterials.2018.12.032 ↗
33. 10.1016/j.biomaterials.2018.10.01010.1016/j.biomaterials.2018.10.010 ↗
34. 10.1002/adfm.20170367410.1002/adfm.201703674 ↗
35. 10.1002/anie.20140218910.1002/anie.201402189 ↗
36. 10.1002/adfm.20160254110.1002/adfm.201602541 ↗
37. 10.1016/j.biomaterials.2018.04.01510.1016/j.biomaterials.2018.04.015 ↗
38. 10.1002/anie.20150981010.1002/anie.201509810 ↗
39. 10.1042/BJ2015094210.1042/BJ20150942 ↗
40. 10.1016/j.cclet.2019.03.03210.1016/j.cclet.2019.03.032 ↗
41. 10.1016/j.cclet.2019.02.00310.1016/j.cclet.2019.02.003 ↗
42. 10.7150/thno.1543310.7150/thno.15433 ↗
43. 10.1016/j.jconrel.2018.12.04210.1016/j.jconrel.2018.12.042 ↗
44. 10.1002/adfm.20160405310.1002/adfm.201604053 ↗
45. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
46. 10.1038/nnano.2014.20810.1038/nnano.2014.208 ↗